Clene (FRA:84C) Capital Expenditure : €-0.06 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clene Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Clene's cash flow for capital expenditures for the three months ended in Mar. 2024 was €-0.01 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.06 Mil.

Clene Capital Expenditure Historical Data

The historical data trend for Clene's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene Capital Expenditure Chart

Clene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

-0.27

-0.32

-1.18

-4.89

-0.30

Clene Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Capital Expenditure	Get a 7-Day Free Trial													-0.26	0.04	-0.05	-0.04	-0.01

Clene Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06 Mil.

Clene (FRA:84C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (FRA:84C) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

CLNN:USA

Address

6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121

Website

https://www.clene.com

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Clene (FRA:84C) Headlines

No Headlines